GENEFLOW LIMITED

Company Registration Number:
04196701 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

GENEFLOW LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

GENEFLOW LIMITED

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 7,836 10,179
Total fixed assets: 7,836 10,179
Current assets
Stocks: 73,518 85,494
Debtors:   77,479 109,130
Cash at bank and in hand: 132,992 140,716
Total current assets: 283,989 335,340
Creditors: amounts falling due within one year:   (143,020) (165,898)
Net current assets (liabilities): 140,969 169,442
Total assets less current liabilities: 148,805 179,621
Creditors: amounts falling due after more than one year:     (18,667)
Total net assets (liabilities): 148,805 160,954
Capital and reserves
Called up share capital: 100,000 100,000
Profit and loss account: 48,805 60,954
Shareholders funds: 148,805 160,954

The notes form part of these financial statements

GENEFLOW LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 15 September 2025
and signed on behalf of the board by:

Name: L Fisher
Status: Director

The notes form part of these financial statements

GENEFLOW LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

GENEFLOW LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 5 5

GENEFLOW LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible Assets

Total
Cost £
At 01 April 2024 74,095
Additions 1,498
At 31 March 2025 75,593
Depreciation
At 01 April 2024 63,916
Charge for year 3,841
At 31 March 2025 67,757
Net book value
At 31 March 2025 7,836
At 31 March 2024 10,179